- Report
- December 2025
- 466 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 381 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 232 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 561 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- November 2025
- 186 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 186 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- August 2025
- 199 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- October 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 200 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- December 2025
- 476 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 301 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 518 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- November 2025
- 183 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 184 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 185 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 191 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP
- Report
- November 2025
- 180 Pages
Global
From €3127EUR$3,545USD£2,747GBP
€3475EUR$3,939USD£3,052GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more